Icono cerrar

Control de la presión arterial con aprocitentán en hipertensión resistente

30/05/25 | 30

Autor/a

María Riestra Fernández

Jefe de sección de Endocrinología

Hospital Universitario Cabueñas

Objetivo

ESH Congress 2024 - Blood pressure control with APROCITENTAN in resistant hypertension. ESH Congress 2024 - Zilebesiran as add-on therapy in patients with hypertension inadequately controlled with a standard antihypertensive medication: efficacy and safety results from the Kardia-2 study

Metodología

Ponencia presentada en el EUS Evidence Update Summit.

Suscribir
Notificar a
0 Comentarios
Inline Feedbacks
View all comments